Healthcare Services

A Significant Growth Driver for the Desmoid Tumors Market Is the Rising Global Cancer Incidence Fuels Growth In The Desmoid Tumor Market

April 1, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Desmoid Tumors Market Between 2026 And 2030?

The desmoid tumors market size has expanded considerably in recent years. This market is projected to expand from $3.15 billion in 2025 to reach $3.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.1%. The historical growth can be ascribed to several factors, including restricted awareness of rare tumors, a reliance on surgical treatment, the absence of targeted drugs, hospital-centric oncology care, and postponed diagnoses.

The market for desmoid tumors is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $4.42 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this anticipated growth include progress in molecular therapies, the expansion of rare disease pipelines, a rise in clinical trials, better diagnostic imaging techniques, and the proliferation of specialty centers. Key trends projected for this period encompass a move towards non-surgical management, the increasing adoption of targeted molecular therapies, the development of watchful waiting approaches, the broadening of multidisciplinary care models, and a heightened emphasis on rare disease research.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13228&type=smp

What Major Drivers Are Influencing Demand In The Desmoid Tumors Market?

The desmoid tumor market is anticipated to expand due to the escalating incidence of cancer. Cancer is identified as a group of diseases marked by the unchecked growth and dissemination of abnormal cells throughout the body, capable of invading and harming surrounding tissues and organs. The worldwide surge in cancer cases has intensified the demand for effective and modern chemotherapeutic agents, positively influencing the desmoid tumor market. For instance, in October 2025, the National Health Service (NHS), a UK-based government health agency, reported 354,820 new cancer diagnoses in 2023, averaging 972 per day, which signifies an increase of 8,605 compared to 2022. Therefore, the growing number of cancer cases is a significant driver for the desmoid tumor market’s growth.

Which Market Segments Are Examined In The Desmoid Tumors Market Study?

The desmoid tumors market covered in this report is segmented –

1) By Treatment: Surgery, Radiation Therapy, Anti-Inflammatory Medication, Hormone Therapy, Chemotherapy, Novel Molecular-Targeted Therapy, Other Treatments

2) By Diagnosis: Biopsy, Electron Microscopic Examination, Immunohistochemical Analysis, Other Diagnosis

3) By End-User: Hospitals And Clinics, Specialty Centers, Other End-Users

Subsegments:

1) By Surgery: Wide Excision, Minimally Invasive Surgery

2) By Radiation Therapy: External Beam Radiation Therapy, Stereotactic Body Radiation Therapy

3) By Anti-Inflammatory Medication: Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Corticosteroids

4) By Hormone Therapy: Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors

5) By Chemotherapy: Traditional Chemotherapy Agents, Combination Chemotherapy

6) By Novel Molecular-Targeted Therapy: Tyrosine Kinase Inhibitors

7) By Other Treatments: Watchful Waiting, Physical Therapy, Pain Management Strategies

What Major Market Trends Are Driving Changes In The Desmoid Tumors Market?

Leading companies in the desmoid tumors market are developing advanced drugs such as nirogacestat for the treatment of desmoid tumors to better satisfy the needs of their existing clientele. Nirogacestat is an orally administered, small-molecule gamma-secretase inhibitor. For instance, in February 2023, SpringWorks Therapeutics Inc., a US-based clinical-stage biopharmaceutical company, announced the U.S. Food and Drug Administration (FDA) acceptance and priority review of its new drug application (NDA) for nirogacestat, intended for treating adults with desmoid tumors. Nirogacestat is understood to operate by preventing the production of notch proteins, which can lead to the death of tumor cells. Desmoid tumors exhibit high levels of notch protein, believed to contribute to their proliferation. Moreover, nirogacestat presents patients with a novel treatment opportunity that could potentially improve outcomes.

Who Are The Primary Competitors In The Desmoid Tumors Market?

Major companies operating in the desmoid tumors market are Pfizer Inc., F.Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Amgen Inc., Eisai Limited, Incyte Corporation, Ipsen Biopharmaceuticals Inc., BeiGene Ltd., Janssen Biotech Inc., Blueprint Medicines Corporation, Debiopharm Group, Clovis Oncology Inc., SpringWorks Therapeutics Inc., Loxo Oncology Inc., Mirati Therapeutics Inc., Iterion Therapeutics Inc., Recepta Pharmaceuticals Inc., Cellestia Biotech AG

Read the full desmoid tumors market report here:

https://www.thebusinessresearchcompany.com/report/desmoid-tumors-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Desmoid Tumors Market?

North America was the largest region in the desmoid tumors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the desmoid tumors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Desmoid Tumors Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13228&type=smp

Browse Through More Reports Similar to the Global Desmoid Tumors Market 2026, By The Business Research Company

Desiccants Global Market Report

https://www.thebusinessresearchcompany.com/report/desiccants-global-market-report

Cancer Cachexia Global Market Report

https://www.thebusinessresearchcompany.com/report/cancer-cachexia-global-market-report

Penile Cancer Global Market Report

https://www.thebusinessresearchcompany.com/report/penile-cancer-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795